| variable | RFS |
| DFS |
| OS |
| |
| T stage | T1 | 90% | 0.437 | 84% | 0.756 | 80% | 0.437 |
| T2 | 88% | 67% | 70% | ||||
| T3 | 82% | 61% | 66% | ||||
| T4a | 71% | 58% | 50% | ||||
| Nodal status | Positive | 85% | 0.536 | 50% | 0.006 | 60% | 0.055 |
| negative | 78.5 | 76% | 70% | ||||
| Stage | Stage II | 77% | 0.734 | 75% | 0.45 | 79% | 0.136 |
| Stage III | 71% | 71% | 72% | ||||
| Stage IVa | 66% | 66% | 59% | ||||
| Safety margins | positive | 72% | 0.828 | 51% | 0.335 | 54% | 0.521 |
| Close | 79% | 57% | 66% | ||||
| negative | 81% | 60% | 69% | ||||
| Perineural invasion | Positive | 55% | 0.011 | 56% | 0.007 | 61% | 0.036 |
| negative | 71% | 69% | 82% | ||||
| Treatment modality | RTH | 43.6% | 0.007 | 62.5% | 0.003 | 48% | 0.009 |
| CCRTH | 73% | 83% | 78% | ||||